Neumedicines Inc. Receives Biomedical Advanced Research and Development Authority (BARDA) Notification of Intent to Exercise Contract Option to Continue Development of HemaMax as Radiation Medical Countermeasure
5/14/2013 10:06:31 AM
More...
|
Achaogen Lands $60 Million Biomedical Advanced Research and Development Authority (BARDA) Contract
4/24/2013 11:28:16 AM
More...
|
Biomedical Advanced Research and Development Authority (BARDA) Continues Support of Flublok® and Panblok® Influenza Vaccines
2/19/2013 9:31:23 AM
More...
|
Cleveland Biolabs Inc. (CBLI) to Present at Biomedical Advanced Research and Development Authority (BARDA) and National Institute of Allergy And Infectious Diseases (NIAID) Sponsored Symposium on Development of Radiation Medical Countermeasures
1/24/2013 9:26:54 AM
More...
|
Biomedical Advanced Research and Development Authority (BARDA) Continues Novavax, Inc. (NVAX)' Influenza Vaccine Programs Following In-Process Review
1/24/2013 9:21:30 AM
More...
|
Biomedical Advanced Research and Development Authority (BARDA) Exercises Contract Option as Emergent BioSolutions (EBS) Achieves Significant Progress in rPA Anthrax
10/5/2012 9:43:44 AM
More...
|
Rapid Micro Biosystems Announces Biomedical Advanced Research and Development Authority (BARDA) Exercises Third Year Option Under Three-Year Contract
9/26/2012 8:29:34 AM
More...
|
Biomedical Advanced Research and Development Authority (BARDA) and Emergent BioSolutions (EBS) Partner to Establish Center for Innovation in Advanced Development and Manufacturing
6/18/2012 3:34:10 PM
More...
|
Emergent BioSolutions (EBS) Secures Additional Funding from Biomedical Advanced Research and Development Authority (BARDA) to Pursue Post-Exposure Prophylaxis Indication for BioThrax
6/4/2012 10:30:31 AM
More...
|
Biomedical Advanced Research and Development Authority (BARDA) Exercises Option With Pfenex Inc. to Extend Contract for the Development of a Recombinant Protective Antigen (rPA) Based Anthrax Vaccine
5/1/2012 11:27:05 AM
More...
|
|